Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.
about
Diagnosis of pulmonary embolism in the coronary care unitLack of association between chronic exposure to biomass fuel smoke and markers of right ventricular pressure overload at high altitudeThe diagnostic significance of signal peptide-complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein-1 levels in pulmonary embolism.Unloading of right ventricle and clinical improvement after ultrasound-accelerated thrombolysis in patients with submassive pulmonary embolismAll patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.Brain natriuretic peptide in the contemporary management of congestive heart failure.Elevated brain natriuretic peptide and troponin I in a woman with generalized weakness and chest pain.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism.Venous thromboembolism: disease burden, outcomes and risk factors.The prognostic value of N-terminal proB-type natriuretic peptide.Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide.N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence?Happy birthday BNPPrognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review.Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins.Prognostic value of brain natriuretic peptide in acute pulmonary embolism.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis.Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism.Review on natriuretic peptides: where we are, where we are going.Evaluation factors of pulmonary embolism severity and prognosis.New prospective for the management of low-risk pulmonary embolism: prognostic assessment, early discharge, and single-drug therapy with new oral anticoagulants.Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients.Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort studyBrain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure.Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism.Factors associated with clinical deterioration shortly after PE.Carbonic anhydrase IX in the prediction of right ventricular dysfunction in patients with hemodynamically stable acute pulmonary embolism.A prognostic model for short term adverse events in normotensive patients with pulmonary embolism.N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases.Elevated gamma glutamyl transferase levels are associated with the location of acute pulmonary embolism. Cross-sectional evaluation in hospital setting.Association of Admission Glucose Level and Improvement in Pulmonary Artery Pressure in Patients with Submassive-type Acute Pulmonary Embolism.Reply: N-Terminal Pro-Brain Natriuretic Peptide Trial Design.Comparison of PESI, echocardiogram, CTPA, and NT-proBNP as risk stratification tools in patients with acute pulmonary embolism.N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
P2860
Q24642975-ACCB50D8-A170-4611-9D67-2335A172AFDEQ28383488-7A2C08F4-F013-4EBC-B79B-D365E19995C1Q33167859-8223F452-A53A-4D4A-84CC-F2968E5A6878Q33908914-DF2279EB-6A9F-455D-BD45-686C515C556EQ35987037-59F27996-A0A5-4E08-9DCA-E406BB7DC462Q36050481-0746E6FF-9777-4958-A6B5-D438F811A950Q36051477-B90F9050-E4B7-4575-AB5C-7B1B0BAA3BD4Q36124913-0E8F4BAA-645E-420D-9F21-3893781EFAA1Q36173298-0E289500-2161-4290-AADE-968C4EE1C641Q36230821-F6840446-F002-480C-B5A1-9699FA7399D5Q36304293-2396CA4A-C1B7-46ED-B9B8-088A8A431B8FQ36931415-C20445DF-075C-40E4-A20B-0B76E5C37FC8Q36987869-433E8C20-6D41-4BE1-BB69-89045C7754FCQ37140899-634CA918-9DBD-45FA-89F2-4458F6AA6253Q37170044-34C88229-8B85-46A4-9188-7A59D7662405Q37192072-39088ADA-7D84-4269-8EB9-A220F44264AEQ37206179-F4B5D0CA-BC9E-45A6-9337-63279980BCE0Q37249841-00C43062-1B69-4691-AD00-BB964E63ACDAQ37277937-AD0CAD64-4BEB-4B2C-9E15-E316957E16D4Q37313438-DE7D78B4-2538-46AD-BD72-5BA76A7D682BQ37360329-D737A0B5-F26A-4371-8DE1-658FC0BD366AQ37835560-AE0F4CDE-3445-4A0F-A354-B9945C4C4455Q37990838-4FE06AA7-00A8-42CF-8342-02D21CC9C378Q38089931-751CCAB9-3D1E-44A5-BFE3-852DB39518B9Q38136163-E43A5A69-9A57-4416-B8A7-0B152FA4A1E5Q38166368-6944553F-E3CA-46CC-8B38-56144A9D967FQ38928454-3F829B2C-EBF5-431E-A028-0724B10B318BQ39386200-79E32F09-1EFA-4047-A124-C4C895F1DDDBQ40238774-6ED4550B-1507-415F-A6EF-6524D0DEDF3FQ44410228-5EAA4C47-7280-4132-AFB2-C22B09BF003EQ44998406-34C38C06-740B-40B2-BDD4-E6E85F06052BQ45998177-2E4CD092-DE2B-47FC-B37F-CA872BA6F65DQ46354484-41463C37-3002-435B-939A-DC689BB1B325Q47402744-07B61BED-4616-417E-AC55-2B93518F2A8CQ47945203-7204E0AE-C7B9-4DC0-99C9-95CF1DFECFCCQ47963489-E4B8A4B3-F07C-403A-B87B-5E768E432D4EQ48284850-69D70175-42D5-43CB-B141-3EA7178BFEBDQ48297145-03BBB7AF-D97C-4FCC-869D-134B19BD1BA3Q48332366-7965036A-B176-4363-84EB-6D7E0874BF8AQ48409814-E309B6B6-28AC-4031-A44B-1F6845E702DF
P2860
Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@en
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@nl
type
label
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@en
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@nl
prefLabel
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@en
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@nl
P2093
P1433
P1476
Low pro-brain natriuretic pept ...... e in acute pulmonary embolism.
@en
P2093
Bernhard Meier
Gert Printzen
Nils Kucher
Otto Martin Hess
Tanja Doernhoefer
P304
P356
10.1161/01.CIR.0000064898.51892.09
P407
P577
2003-03-24T00:00:00Z